πŸ‡ΊπŸ‡Έ FDA
Patent

US 8778944

Pyridazinone compounds

granted A61KA61K9/2059A61P

Quick answer

US patent 8778944 (Pyridazinone compounds) held by Takeda Pharmaceutical Company Limited expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K9/2059, A61P, A61P25/00, A61P25/14